Article

Quantification of mitral valve regurgitation in dogs with degenerative mitral valve disease by use of the proximal isovelocity surface area method

Unité de Cardiologie d'Alfort, Ecole Nationale Vétérinaire d'Alfort, 7 avenue du Général de Gaulle, F-94 704 Maisons-Alfort cedex, France.
Journal of the American Veterinary Medical Association (Impact Factor: 1.67). 09/2007; 231(3):399-406. DOI: 10.2460/javma.231.3.399
Source: PubMed

ABSTRACT To determine the within-day and between-day variability of regurgitant fraction (RF) assessed by use of the proximal isovelocity surface area (PISA) method in awake dogs with degenerative mitral valve disease (MVD), measure RF in dogs with MVD, and assess the correlation between RF and several clinical and Doppler echocardiographic variables.
Prospective study.
6 MVD-affected dogs with no clinical signs and 67 dogs with MVD of differing severity (International Small Animal Cardiac Health Council [ISACHC] classification).
The 6 dogs were used to determine the repeatability and reproducibility of the PISA method, and RF was then assessed in 67 dogs of various ISACHC classes. Mitral valve regurgitation was also assessed from the maximum area of regurgitant jet signal-to-left atrium area (ARJ/LAA) ratio determined via color Doppler echocardiographic mapping.
Within- and between-day coefficients of variation of RF were 8% and 11%, respectively. Regurgitation fraction was significantly correlated with ISACHC classification and heart murmur grade and was higher in ISACHC class III dogs (mean +/- SD, 72.8 +/- 9.5%) than class II (57.9 +/- 20.1%) or I (40.7 +/- 19.2%) dogs. Regurgitation fraction and left atriumto-aorta ratio, fractional shortening, systolic pulmonary arterial pressure, and ARJ/LAA ratio were significantly correlated.
Results suggested that RF is a repeatable and reproducible variable for noninvasive quantitative evaluation of mitral valve regurgitation in awake dogs. Regurgitation fraction also correlated well with disease severity. It appears that this Doppler echocardiographic index may be useful in longitudinal studies of MVD in dogs.

0 Bookmarks
 · 
251 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate vena contracta and other echocardiographic measures of myxomatous mitral valve disease (MMVD) severity in a multivariable analysis of survival in dogs. 70 dogs diagnosed with MMVD from stored echocardiographic images that met study inclusion criteria. Left heart dimensions were measured as well as mitral regurgitant jet area/left atrial area (JAR), early mitral filling velocity (Evel), extent of mitral valve prolapse in right and left views (ProlR, ProlL), Prol indexed to aortic diameter (ProlR:Ao, ProlL:Ao), presence of a flail leaflet (FlailR, FlailL), and mitral regurgitation vena contracta diameter (VCR, VCL) indexed to aortic diameter (VCR:Ao, VCL:Ao). Follow-up from referring veterinarians was obtained by questionnaire or telephone to determine survival times. Inter- and intra-observer agreement was evaluated with Bland-Altman plots and weighted Kappa analysis. Survival was analyzed using Kaplan-Meier curves, logrank tests and Cox's proportional hazards. Logrank analysis showed VCL:Ao, VCR:Ao, FlailL, ProlR:Ao, ProlL:Ao, left ventricular internal dimension in diastole indexed to aortic diameter (LVIDD:Ao) >2.87, left atrium to aorta ratio (LA/Ao) >1.6, and Evel >1.4 m/s were predictors of cardiac mortality. In a multivariable analysis, the independent predictors of cardiac mortality were Evel >1.4 m/s [hazard ratio (HR) 5.0, 95% confidence interval (CI) 2.5-10.3], FlailL (HR 3.1, 95% CI 1.3-7.9), and ProlR:Ao (HR 2.8, 95% CI 1.3-6.3). Echocardiographic measures of mitral regurgitation severity and mitral valve pathology provide valuable prognostic information independent of chamber enlargement in dogs with MMVD. Copyright © 2014 Elsevier B.V. All rights reserved.
    Journal of veterinary cardiology: the official journal of the European Society of Veterinary Cardiology 01/2015; DOI:10.1016/j.jvc.2014.11.001
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mixomatous mitral valve disease (MMVD) is one of the most common cardiac abnormalities in dogs and humans that can lead to cardiac heart failure (CHF). Its diagnosis remains based on echocardiography and clinical signs. However, the early diagnose of MMVD can contribute to a better prognosis and avoid CHF. The aim of this study was to evaluate the clinical, radiographic and echocardiographic presence of CHF in dogs with MMVD in combination with a statistical model as a mathematical tool. For this purpose, dogs were divided into three groups (healthy; MMVD without CHF; and MMVD with CHF), according the clinical, radiographic and echocardiographic evaluation findings. Thus, linear discriminant functions were obtained by analyzing the variables weight, body surface area, aortic diameter, the ratio of the left atrium/aortic diameter, the ratio between the mitral regurgitation jet area and the left atrial area, vena contracta diameter and mitral valve proximal isovelocity surface area. Then, mathematical equations were established for each group of dogs. Statistical functions obtained in this study enabled to classify the dogs, regarding the presence of CHF with a probability of correct classification of 90.4%. Thus the statistical model demonstrated that it could be used as an auxiliary method for identifying CHF in dogs with MMVD.
    Arquivo Brasileiro de Medicina Veterinária e Zootecnia 12/2014; 66(6):1727-1734. DOI:10.1590/1678-6800 · 0.20 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die Mitralklappenendokardiose – Aktueller Stand der Diagnose und Therapie Die Mitralklappenendokardiose ist die häufigste erworbene Herzerkrankung beim Hund. Zusammenfassung Die Mitralklappenendokardiose ist die häufigste erworbene Herzerkrankung beim Hund. In den letzten Jahren wurden die diagnostischen Methoden weiterentwickelt und verschiedene therapeutische Optionen anhand einer Vielzahl von Studien untersucht. Das CHIEF-Klassifikationsschema ermöglicht eine eindeutige Einteilung von Hunden in verschiedene Stadien ihrer Herzerkrankungen und erleichtert damit Therapieentscheidungen. Während für die Behandlung symptomatischer Hunde (Stadium CHIEF_C) ein Konsens hinsichtlich der Therapie besteht, ist die optimale Therapie für asymptomatische Hunde (Stadium CHIEF_B) nicht endgültig geklärt. Ziel dieses Artikels ist es, den aktuellen Stand der Wissenschaft zu diskutieren, um eine bestmögliche Versorgung des Patienten mit Mitralklappenendokardiose zu ermöglichen. Schlüsselwörter Herzinsuffizienz, Behandlung, Graduierung, CHIEF-Klassifikation Summary Degenerative mitral valve disease – Current state of diagnosis and therapy Degenerative mitral valve disease is the most common acquired heart disease in dogs. In recent years, the diagnostic methods have advanced and therapeutic options have been evaluated in several studies. To be able to classify and treat this disease uniformly, it is strongly advised to use the four-stage CHIEF (Canine Heart Failure International Expert Forum) classification scheme. While there is consent regarding the treatment of symptomatic dogs (CHIEF C), the optimal treatment of asymptomatic dogs (CHIEF B) has not been agreed upon. The aim of this article is to present and discuss current scientific knowledge enabling the best possible care of dogs with degenerative mitral valve disease.
    Kleintierpraxis 06/2014; 59(6):329–352. DOI:10.2377/0023-2076-59-329 · 0.10 Impact Factor

Full-text (2 Sources)

Download
5 Downloads
Available from
Mar 17, 2015